title: Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect.
abstract: Loss-of-function variants within the filaggrin gene (FLG) increase the risk of atopic dermatitis. FLG also demonstrates intragenic copy number variation (CNV), with alleles encoding 10, 11, or 12 filaggrin monomers; hence, CNV may affect the amount of filaggrin expressed in the epidermis. A total of 876 Irish pediatric atopic dermatitis cases were compared with 928 population controls to test the hypothesis that CNV within FLG affects the risk of atopic dermatitis independently of FLG-null mutations. Cases and controls were screened for CNV and common FLG-null mutations. In this population the 11-repeat allele was most prevalent (allele frequency 51.5%); the 10-repeat allele frequency was 33.9% and the 12-repeat allele frequency was 14.6%. Having excluded FLG mutation carriers, the control group had a significantly higher number of repeats than cases (χ(2) P=0.043), and the odds ratio of disease was reduced by a factor of 0.88 (95% confidence interval 0.78-0.98, P=0.025) for each additional unit of copy number. Breakdown products of filaggrin were quantified in tape-stripped stratum corneum from 31 atopic dermatitis patients and urocanic acid showed a positive correlation with total copy number. CNV within FLG makes a significant, dose-dependent contribution to atopic dermatitis risk, and therefore treatments to increase filaggrin expression may have therapeutic utility.
authors.affiliation: Dermatology and Genetic Medicine, Division of Molecular Medicine, University of Dundee, Dundee, UK. s.j.brown@dundee.ac.uk
authors.forename: Sara J
authors.initials: SJ
authors.lastname: Brown
authors.forename: Karin
authors.initials: K
authors.lastname: Kroboth
authors.forename: Aileen
authors.initials: A
authors.lastname: Sandilands
authors.forename: Linda E
authors.initials: LE
authors.lastname: Campbell
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Pohler
authors.forename: Sanja
authors.initials: S
authors.lastname: Kezic
authors.forename: Heather J
authors.initials: HJ
authors.lastname: Cordell
authors.forename: W H Irwin
authors.initials: WH
authors.lastname: McLean
authors.forename: Alan D
authors.initials: AD
authors.lastname: Irvine
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D002675:Child, Preschool; D003876:Dermatitis, Atopic / Q000453:epidemiology* / Q000235:genetics* / Q000378:metabolism; D005260:Female; D000091344:Filaggrin Proteins; D018628:Gene Dosage / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000453:epidemiology / Q000235:genetics; D005838:Genotype; D006801:Humans; D007381:Intermediate Filament Proteins / Q000235:genetics* / Q000378:metabolism; D007494:Ireland / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D012307:Risk Factors; D012867:Skin / Q000378:metabolism; D014560:Urocanic Acid / Q000378:metabolism
chemical_list: C000717249:FLG protein, human; D000091344:Filaggrin Proteins; D007381:Intermediate Filament Proteins; D014560:Urocanic Acid
references.citation: Nature. 2010 Apr 1;464(7289):713-20
references.pmid: 20360734
references.citation: J Invest Dermatol. 2007 Jun;127(6):1282-4
references.pmid: 17502856
references.citation: J Cell Sci. 2009 May 1;122(Pt 9):1285-94
references.pmid: 19386895
references.citation: Genome Biol. 2010;11(5):R52
references.pmid: 20482838
references.citation: J Dermatol Sci. 2008 Jun;50(3):209-15
references.pmid: 18280705
references.citation: Biochim Biophys Acta. 1983 Apr 14;744(1):28-35
references.pmid: 6187370
references.citation: Nat Genet. 2008 Sep;40(9):1053-5
references.pmid: 18677311
references.citation: Biochemistry. 1990 Oct 9;29(40):9432-40
references.pmid: 2248957
references.citation: Nat Rev Genet. 2011 May;12(5):363-76
references.pmid: 21358748
references.citation: Nat Genet. 2006 Apr;38(4):441-6
references.pmid: 16550169
references.citation: Nat Genet. 2009 Feb;41(2):211-5
references.pmid: 19169253
references.citation: Am J Hum Genet. 2009 Jun;84(6):807-13
references.pmid: 19463983
references.citation: BMJ. 2006 Mar 11;332(7541):584-8
references.pmid: 16528081
references.citation: Nature. 2010 Apr 1;464(7289):704-12
references.pmid: 19812545
references.citation: Genome Biol. 2009;10(11):R125
references.pmid: 19900272
references.citation: J Invest Dermatol. 2010 Apr;130(4):979-84
references.pmid: 20016497
references.citation: N Engl J Med. 2005 Jun 2;352(22):2314-24
references.pmid: 15930422
references.citation: Br J Dermatol. 1994 Sep;131(3):406-16
references.pmid: 7918017
references.citation: J Invest Dermatol. 2008 Aug;128(8):2117-9
references.pmid: 18305568
references.citation: BMJ. 2009 Jul 09;339:b2433
references.pmid: 19589816
references.citation: Nat Genet. 2006 Mar;38(3):337-42
references.pmid: 16444271
references.citation: Nat Genet. 2007 May;39(5):650-4
references.pmid: 17417636
references.citation: Allergy. 2011 Jul;66(7):934-40
references.pmid: 21261659
references.citation: Br J Dermatol. 2000 Feb;142(2):288-97
references.pmid: 10730763
references.citation: Science. 2004 Jul 23;305(5683):525-8
references.pmid: 15273396
references.citation: J Invest Dermatol. 1996 May;106(5):989-92
references.pmid: 8618063
references.citation: Nature. 2008 May 1;453(7191):56-64
references.pmid: 18451855
references.citation: Arch Dermatol Res. 2005 Dec;297(6):235-41
references.pmid: 16261374
references.citation: Int J Clin Pract. 2006 Aug;60(8):984-92
references.pmid: 16893440
references.citation: J Allergy Clin Immunol. 2009 Jun;123(6):1361-70.e7
references.pmid: 19501237
references.citation: J Invest Dermatol. 2011 Jan;131(1):67-73
references.pmid: 20739951
references.citation: J Am Acad Dermatol. 1994 Jan;30(1):35-9
references.pmid: 8277028
references.citation: Br J Dermatol. 2011 Jul;165(1):106-14
references.pmid: 21428977
references.citation: Nat Genet. 2004 Sep;36(9):949-51
references.pmid: 15286789
references.citation: J Allergy Clin Immunol. 2008 Apr;121(4):940-46.e3
references.pmid: 18313126
references.citation: Dermatol Ther. 2004;17 Suppl 1:43-8
references.pmid: 14728698
references.citation: Pediatr Allergy Immunol. 2007 Mar;18(2):149-53
references.pmid: 17338788
references.citation: J Allergy Clin Immunol. 2010 Jan;125(1):170-4.e1-2
references.pmid: 20109745
references.citation: J Invest Dermatol. 2002 Oct;119(4):905-12
references.pmid: 12406337
references.citation: Nature. 2006 Nov 23;444(7118):444-54
references.pmid: 17122850
references.citation: J Allergy Clin Immunol. 2007 Dec;120(6):1406-12
references.pmid: 17980411